Skip to main content Back to Top

GLP Practice Insights: GLP-1 Receptor Agonists and Muscle Loss (CE)

June 6, 2026


ABOUT THIS PODCAST

This podcast explores the growing concern of muscle loss associated with GLP-1 receptor agonist therapy for obesity management. It highlights the need for greater awareness among clinicians and patients, emphasizing strategies such as adequate protein intake, strength training, and emerging pharmacologic options to preserve muscle mass. The discussion underscores the importance of muscle preservation for long-term health and quality of life in individuals using GLP-1 therapies.


SPEAKERS

  • Michelle Patterson, PharmD, BCACP, CDCES
    Clinical Pharmacy Specialist, Main Line Health
  • Crystal Deas, PharmD, BCPS
    Professor of Pharmacy Practice, Samford University McWhorter School of Pharmacy
    Affiliate Clinical Pharmacist, Cooper Green Mercy Health Services Authority
  • Nima Patel-Shori, PharmD, BCACP
    Ambulatory Care Clinical Pharmacist, Temple Internal Medicine Associates
    Program Director, Postgraduate Your 2 Ambulatory Care Pharmacy Resident, Temple University School of Pharmacy

LISTEN ON


iTunes      Google            Spotify      TuneIn      iHeart Radio


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Podcasts